SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,909.68 -325.78
( -0.42%)

Global Indices

Nasdaq

53,487.79 123.39
(0.23%)

Dow Jones

7,729.14 16.38
(0.21%)

Hang Seng

65,335.94 -2,124.79
(-3.15%)

Nikkei 225

10,747.45 19.41
(0.18%)

Forex

USD-INR

95.60 0.07
(0.07%)

EUR-INR

110.76 0.24
(0.21%)

GBP-INR

129.56 0.29
(0.22%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nephro Care India Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

92991

INE0SUN01013

34.4868498

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NEPHROCARE

24.28

136.51

EPS(TTM)

Face Value()

Div & Yield %

3.41

Back

Bal Pharma consolidated net profit rises 270.83% in the December 2025 quarter

Feb 12,2026

Net profit of Bal Pharma rose 270.83% to Rs 1.78 crore in the quarter ended December 2025 as against Rs 0.48 crore during the previous quarter ended December 2024. Sales rose 19.88% to Rs 87.69 crore in the quarter ended December 2025 as against Rs 73.15 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	87.69	73.15	20
OPM %	10.88	10.59	-
PBDT	5.02	3.25	54
PBT	1.79	0.57	214
NP	1.78	0.48	271

76,909.68 -325.78 ( -0.42%)

53,487.79 123.39 (0.23%)

7,729.14 16.38 (0.21%)

65,335.94 -2,124.79 (-3.15%)

10,747.45 19.41 (0.18%)

95.60 0.07 (0.07%)

110.76 0.24 (0.21%)

129.56 0.29 (0.22%)

0.60 0.00 (0.12%)